DETECT
DEAD

Serial Number

88902307

Owner

The Broad Institute Inc.

Attorney

Jennifer S. Stachniak

Filing Date

May 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DETECT Trademark

Serial Number: 88902307

DETECT is a trademark filed by The Broad Institute Inc. on May 5, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

The Broad Institute Inc. (46 trademarks)

415 Main Street
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

May 5, 2020

Registration Date

Not Registered

Published for Opposition

September 8, 2020

Goods & Services

RNA-guided therapeutic pharmaceuticals for the treatment of diseases and medical conditions, namely, allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections; diagnostic preparations for medical or veterinary purposes; Reagent paper for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections; Medical diagnostic reagents and assays for testing of body fluids

Diagnostic preparations for scientific or research use; Reagent paper other than for medical purposes

Disease and pest control treatments for agriculture, namely, breeding and propagating genetically modified plants with increased disease resistance; performing diagnosis of diseases; Medical testing for diagnostic or treatment purposes; Providing medical information from a website; Providing a website featuring information in the field of the diagnosis and treatment of allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 8, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 8, 2024 ABN6
ASSIGNED TO EXAMINER
Oct 23, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2023 EXRA
SOU EXTENSION 5 GRANTED
Sep 11, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 11, 2023 AITU
SOU EXTENSION 5 FILED
Sep 1, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 1, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2023 EXRA
SOU EXTENSION 4 GRANTED
Feb 28, 2023 EX4G
SOU EXTENSION 4 FILED
Feb 28, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 28, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 3, 2022 EXRA
SOU EXTENSION 3 GRANTED
Sep 1, 2022 EX3G
SOU EXTENSION 3 FILED
Sep 1, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 10, 2022 EXRA
SOU EXTENSION 2 GRANTED
Feb 8, 2022 EX2G
SOU EXTENSION 2 FILED
Feb 8, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2021 EXRA
SOU EXTENSION 1 GRANTED
Aug 26, 2021 EX1G
SOU EXTENSION 1 FILED
Aug 26, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 26, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 2, 2021 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jan 21, 2021 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 7, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 5, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 5, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2020 CNEA
ASSIGNED TO EXAMINER
Jul 29, 2020 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 25, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2020 REAP
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 19, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2020 NWOS
NEW APPLICATION ENTERED
May 8, 2020 NWAP